Another more recent study observed SF3B1 mutations in 63% (33 of 52) of patients with RARS; frequency was highest among patients with RARS (83%) relative to other World Health Organization (WHO) morphologic categories (Zhu et al., 2016). Here, SF3B1 is linked to myelodysplastic syndrome with ring sideroblasts.